Navigation Links
EAG Announces New General Manager of Release-To-Production (RTP) Division
Date:3/15/2013

Santa Clara, California (PRWEB) March 15, 2013

The world's leading, fully integrated, independent laboratory network, providing high value expert analytical and testing services to a wide range of industries and end users, is pleased to announce the appointment of Aram Sarkissian as the new General Manager of EAG’s Release-To-Production (RTP) division.

Mr. Sarkissian is a seasoned leader with two decades of customer-facing experience in the semiconductor services market. He joined EAG in 2007 as part of the acquisition of Accurel, where he served in a variety of roles with increasing responsibilities in Engineering, Sales & Marketing, and management to help build the business into a leading lab services provider. Upon joining EAG, Mr. Sarkissian was instrumental in the integration of Accurel and moved into a VP of Sales role at EAG where he continued to help grow and shape the RTP business division and establish it as a world class semiconductor services organization. Mr. Sarkissian holds a BS in Electrical Engineering and Computer Science from the University of California at Berkeley.

“I am honored to accept the appointment as General Manager of the RTP Division and am extremely enthusiastic about our prospects looking forward. The services provided by our Division are second to none.” remarked Mr. Sarkissian.

Harry Davoody, CEO of EAG, stated “Aram has a deep understanding of the service requirements and the high bar set by the semiconductor industry. The credibility he has earned with our customers will serve him well in his new role.”

About Evans Analytical Group
EAG is the world's leading, fully integrated, independent laboratory network. EAG's Materials Characterization Division provides high value analytical services focused on surface analysis and materials characterization in support of high technology industries. The Company's Release to Production Division provides expert engineering service and support from chip tape-out to volume production in support of the electronics industry. EAG’s Environmental Fate, Chemistry and Ecotoxicology (EFCE) Division provides analytical chemistry, environmental fate, metabolism and eco-toxicology services for agrochemicals, industrial chemicals, pharmaceuticals and animal health products. EAG has an international network of 21 laboratories and sites and serves more than 5,500 customers worldwide. http://www.eag.com

EAG is majority owned by Odyssey Investment Partners, LLC, a leading private equity firm with more than $2 billion in capital under management. Odyssey makes majority, control investments primarily in established middle-market industrial manufacturing and business services companies in a variety of industries. Further information regarding Odyssey Investment Partners can be found at http://www.odysseyinvestment.com.

Read the full story at http://www.prweb.com/releases/RTP/division/prweb10536621.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update
2. Senomyx Announces Fourth Quarter And Full Year 2012 Financial Results And Initiation Of New Direct Sales Strategy
3. Verenium Announces Preliminary Financial Results For Fiscal 2012
4. Probiotic Action Announces Probiotics Lead the Digestive Health Market
5. Annual Conference about Technology Solutions for People with Disabilities Announces Program
6. DistinctBright, Probiotic Cleaner, Announces their Probiotic Cleaner is Safe for Pets
7. Research and Markets Announces the Release of Transdermal Pain Management to 2016. Products, Markets, Forecasts and Opportunities
8. Z Trim Holdings Announces Conclusion of Successful Warrant Exercise Program: Raises $2.195 Million
9. EAG Announces General Manager of Environmental Fate, Chemistry and Ecotoxicology (EFCE) Division
10. Pittcon 2013 Announces Exposition Highlights
11. Real Time Genomics Announces Formation of its Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/10/2019)... ... April 10, 2019 , ... RoosterBio ... multiple agreements to help companies advance their innovations to clinical testing more ... synthetic biology companies that are gene editing therapeutic cells for advanced functionality ...
(Date:4/9/2019)... ... April 09, 2019 , ... USDM Life Sciences ... life sciences organizations to accelerate innovation and maximize productivity, announces that nearly 100 ... 12 months. , USDM’s Cloud Assurance is a managed subscription service ...
(Date:4/9/2019)... ... April 09, 2019 , ... The American Society of Gene & Cell ... team, including a new addition to the presidential line of succession, at the ... the Society's leadership team for a three-year term (2019-2021). , All five incoming members ...
(Date:4/8/2019)... ... April 08, 2019 , ... US Capital Global Securities , an ... equity investment in the privately held pharmaceutical company, S1 Biopharma (“S1”). , S1 has ... at female hypoactive sexual dysfunction disorder and is ready to begin phase 2b trials. ...
Breaking Biology Technology:
(Date:4/9/2019)... ... ... The McLeod Center for Cancer Treatment and Research has been ... conducted by an independent, third-party panel of experts in radiation oncology, patient safety and ... McLeod is the only such cancer center in South Carolina. The hospital also represents ...
(Date:4/4/2019)... Calif. (PRWEB) , ... April 02, 2019 , ... ... clinical genetics testing company, will present results demonstrating that RNA genetic testing (RGT), ... genetic testing. This study, awarded as a Top Rated poster, is one of ...
(Date:3/29/2019)... ... March 28, 2019 , ... ... programme, a new PT programme entirely dedicated to Chinese biobanks was launched in ... Environmental Repositories (ISBER) and the Biobank Branch, China Medicinal Biotech Association (BBCMBA). The ...
Breaking Biology News(10 mins):